Quantcast
Viewing all articles
Browse latest Browse all 186

Second-line therapy for progressive, high-risk prostate cancer: time for a STAMPEDE-like trial?

Let’s say you are 58 years of age, in apparently excellent health for your age, when you get diagnosed with high-risk prostate cancer, based on a Gleason score of 4 + 4 = 8, a PSA level of 3.7, and a clinical stage of T1c, with 4/12 biopsy cores positive for cancer. It doesn’t take […]Image may be NSFW.
Clik here to view.

Viewing all articles
Browse latest Browse all 186

Trending Articles